Stem cells and beta cell replacement therapy: a prospective health technology assessment study.

Klemens WallnerRene G PedrozaIsaac AwotweJames M PiretPeter A SeniorA M James ShapiroChristopher McCabe

Published in: BMC endocrine disorders (2018)

Such a technology can improve treatment access and quality of life for patients through increased graft supply and protection. Stem cell-based implants can be a feasible way of treating a wide range of patients with type 1 diabetes.

Keyphrases

stem cells
replacement therapy
end stage renal disease
cell therapy
ejection fraction
newly diagnosed
public health
healthcare
chronic kidney disease
smoking cessation
mental health
prognostic factors
single cell
peritoneal dialysis
climate change
human health